Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4661)
All Articles published online
|
Jan 28, 2011 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tsubota A, Fujise K, Namiki Y, Tada N. Peginterferon and ribavirin treatment for hepatitis C virus infection. World J Gastroenterol 2011; 17(4): 419-432 [PMID: 21274371 DOI: 10.3748/wjg.v17.i4.419] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i4/419.htm |
| Number | Citing Articles |
| 1 |
Chao Chen, Hui Qiu, Jian Gong, Qing Liu, Han Xiao, Xin-Wen Chen, Bin-Lian Sun, Rong-Ge Yang. (−)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus. Archives of Virology 2012; 157(7): 1301 doi: 10.1007/s00705-012-1304-0
|
| 2 |
Rabia Aslam, Syed Mohsin Raza, Humeira Naeemi, Bushra Mubarak, Nadeem Afzal, Saba Khaliq. SOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatment. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3506-5
|
| 3 |
Francesco Azzaroli, Marco Montagnani, Alberto Porro, Domenico Fiorillo, Giuseppe Mazzella. The future of dual therapy for hepatitis C virus. Future Virology 2014; 9(10): 905 doi: 10.2217/fvl.14.78
|
| 4 |
Yoshiaki Iwasaki, Ryo-ichi Okamoto, Yasushi Ishii, Yasuyuki Araki, Noriaki Hashimoto, Kazuhide Yamamoto. Randomized trial of low-dose peginterferon α-2b plus low and escalating doses of ribavirin in older patients with chronic hepatitis C with high viral load genotype 1. Journal of Medical Virology 2015; 87(12): 2082 doi: 10.1002/jmv.24276
|
| 5 |
Kandoussi Nadia, Elannaz Hicham, Tagajdid Mohamed Reda, Touil Nadia, Bouaiti Elarbi, Elkabbaj Saâd, Zouhdi Mimoun, Mrani Saâd. The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C. Gene 2015; 568(1): 31 doi: 10.1016/j.gene.2015.05.010
|
| 6 |
Jie Guan, Bo Wen, Yao Deng, Ke Zhang, Hong Chen, Xiaobing Wu, Li Ruan, Wenjie Tan. Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-506
|
| 7 |
Pietro Vajro, Claudio Veropalumbo, Sergio Maddaluno, Mariacarolina Salerno, Giancarlo Parenti, Claudio Pignata. Treatment of children with chronic viral hepatitis: what is available and what is in store. World Journal of Pediatrics 2013; 9(3): 212 doi: 10.1007/s12519-013-0426-0
|
| 8 |
Mohamed Abdel‐Samiee, Mohamed I. Youssef, Fathy Elghamry, Mahmoud Bazeed, Mohamed Al‐Shorbagy, Helmy Shalaby, Hossam Shabana, Eman Abdelsameea, Hesham El Sayed Lashin, Hossam M. Farid El Zamek, Tarek Esam, Mohammad AbdElhameed Ahmed Alwaseef, Housam Ahmed Helmy, Feras Almarshad, Fatma A. Khalaf, Badawy W. AboBakr Yossef, Arafat Kassem, Basant Mostafa Gabr, Ahmed Abdelfattah, Hind S. AboShabaan, Galal Abdelhameed Aboufarrag, Marwa M. Omar, Mohammed Saied Bakeer, Mohammed S. Imam, Essam S. Ibrahim, Shimaa Y Kamel, Talaat Allisy, Omima Sayed Mohammed, Ali Farahat, Mohsen M. El‐Khayat, Mohamed Abdelrafaa Hassan Sekeen, Eman Mohammed Zaher, Ashraf Said, Ahmed Abuamer, Essam Elmahdi. A multicentric and nationwide predictive study role of T cell sub‐population in the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic hepatitis C patients. Journal of Medical Virology 2023; 95(12) doi: 10.1002/jmv.29248
|
| 9 |
Takami Akagi, Mitsuru Akashi. Nanomaterials in Pharmacology. Methods in Pharmacology and Toxicology 2016; : 439 doi: 10.1007/978-1-4939-3121-7_22
|
| 10 |
RIE OSAKI, TAKASHI NISHIMURA, TAKAYUKI TAKEUCHI, HIROTSUGU IMAEDA, YOSHIAKI OKUMURA, MAKOTO SHIOYA, TAMIO NAKAHARA, SHIGEKI BAMBA, SHINOBU NAKAJO, YOSHIHIDE FUJIYAMA, AKIRA ANDOH. Interleukin-28B polymorphisms are associated with an early viral response in patients receiving hepatitis C therapy. Experimental and Therapeutic Medicine 2011; 2(4): 715 doi: 10.3892/etm.2011.250
|
| 11 |
Heidar Sharafi, Ali Pouryasin, Seyed Moayed Alavian, Bita Behnava, Maryam Keshvari, Leila Mehrnoush, Shima Salimi, Osveh Kheradvar. Development and Validation of a Simple, Rapid and Inexpensive PCR-RFLP Method for Genotyping of Common IL28B Polymorphisms: A Useful Pharmacogenetic Tool for Prediction of Hepatitis C Treatment Response. Hepatitis Monthly 2012; 12(3): 190 doi: 10.5812/hepatmon.5117
|
| 12 |
J. Angulo, K. Pino, C. Pavez, F. Biel, P. Labbé, J. F. Miquel, A. Soza, M. López‐Lastra. Genetic variations in host IL28B links to the detection of peripheral blood mononuclear cells–associated hepatitis C virus RNA in chronically infected patients. Journal of Viral Hepatitis 2013; 20(4): 263 doi: 10.1111/jvh.12076
|
| 13 |
F.S. Alhamlan, M.N. Al‐Ahdal, N.Z. Khalaf, A.A. Abdo, F.M. Sanai, H.I. Al‐Ashgar, M. ElHefnawi, A. Zaid, A.A. Al‐Qahtani. Hepatitis C virus genotype 1: How genetic variability of the core protein affects the response to pegylated‐interferon and ribavirin therapy. Journal of Medical Virology 2014; 86(2): 224 doi: 10.1002/jmv.23823
|
| 14 |
Essam M. Akl, Ahmed A. Salah. Effect of new oral direct acting antiviral therapy on sexual function in male patients with hepatitis C virus. Andrologia 2020; 52(11) doi: 10.1111/and.13835
|
| 15 |
Mamata Panigrahi, Michael A. Palmer, Joyce A. Wilson. MicroRNA-122 Regulation of HCV Infections: Insights from Studies of miR-122-Independent Replication. Pathogens 2022; 11(9): 1005 doi: 10.3390/pathogens11091005
|
| 16 |
Nedim Hadžić, Ulrich Baumann, Pat McKiernan, Valerie McLin, Valerio Nobili. Long-term challenges and perspectives of pre-adolescent liver disease. The Lancet Gastroenterology & Hepatology 2017; 2(6): 435 doi: 10.1016/S2468-1253(16)30160-1
|
| 17 |
Bukowska-Ośko Iwona, Perlejewski Karol, Caraballo Cortés Kamila, Agnieszka Pollak, Berak Hanna, Pawełczyk Agnieszka, Horban Andrzej, Joanna Kosińska, Rafał Płoski, Laskus Tomasz, Radkowski Marek. Next-generation sequencing analysis of new genotypes appearing during antiviral treatment of chronic hepatitis C reveals that these are selected from pre-existing minor strains.
Journal of General Virology 2018; 99(12): 1633 doi: 10.1099/jgv.0.001160
|
| 18 |
Sonja Vukadin, Ana Petrović, Dragan Primorac, Martina Smolić. Pharmacogenomics in Clinical Practice. 2023; : 413 doi: 10.1007/978-3-031-45903-0_23
|
| 19 |
Aninthita Phalaphol, Kanyarat Thueng-in, Jeeraphong Thanongsaksrikul, Ornnuthchar Poungpair, Kunan Bangphoomi, Nitat Sookrung, Potjanee Srimanote, Wanpen Chaicumpa. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity. Journal of Virological Methods 2013; 194(1-2): 289 doi: 10.1016/j.jviromet.2013.08.032
|
| 20 |
Mohammad Saeid Rezaee-Zavareh, Khashayar Hesamizadeh, Bita Behnava, Seyed Moayed Alavian, Mohammad Gholami-Fesharaki, Heidar Sharafi. Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis. Annals of Hepatology 2017; 16(2): 188 doi: 10.5604/16652681.1231577
|
| 21 |
Daniele Serranti, Giuseppe Indolfi, Massimo Resti. New treatments for chronic hepatitis C: An overview for paediatricians. World Journal of Gastroenterology 2014; 20(43): 15965-15974 doi: 10.3748/wjg.v20.i43.15965
|
| 22 |
El‐Sayed Ibrahim, Mohamed Abdel‐Samiee, Mohamed I. Youssef, Helmy El‐Shazly, Abd‐ElAleem A.El‐Gendy, Ayman Ahmed Sakr, Doaa Elwazzan, Mervat Ragab Nassar, Amr Aly Elshormilisy, Ahmad Madkour, Mostafa Kamal, Yasmine M. Amrousy, Sally Waheed Elkhadry, Eman Abdelsameea. Variceal recurrence 4 years post endoscopic band ligation in hepatitis C patients who achieved sustained virological response with oral direct‐acting antiviral therapy. Journal of Viral Hepatitis 2021; 28(2): 279 doi: 10.1111/jvh.13426
|
| 23 |
Daniela Klotz, Wolfgang Baumgärtner, Ingo Gerhauser. Type I interferons in the pathogenesis and treatment of canine diseases. Veterinary Immunology and Immunopathology 2017; 191: 80 doi: 10.1016/j.vetimm.2017.08.006
|
| 24 |
Sandra Pisonero-Vaquero, María V García-Mediavilla, Francisco Jorquera, Pedro L Majano, Marta Benet, Ramiro Jover, Javier González-Gallego, Sonia Sánchez-Campos. Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin. Laboratory Investigation 2014; 94(3): 262 doi: 10.1038/labinvest.2013.156
|
| 25 |
C Torti, M Zazzi, L Abenavoli, F Trapasso, F Cesario, D Corigliano, L Cosco, C Costa, RL Curia, M De Rosa, G Foti, C Giraldi, R Leone, MC Liberto, D Lucchino, N Marascio, R Masciari, G Matera, V Pisani, N Serrao, L Surace, E Zicca, F Castelli, M Ciccozzi, M Puoti, A Focà. Future research and collaboration: the “SINERGIE” project on HCV (South Italian Network for Rational Guidelines and International Epidemiology). BMC Infectious Diseases 2012; 12(S2) doi: 10.1186/1471-2334-12-S2-S9
|
| 26 |
Mehmet Bayram, Ali Riza Koksal, Huseyin Alkim, Salih Boga, Meltem Ergun, Osman Ozdogan, Engin Altinkaya, Canan Alkim. First Week HCV RNA Level Under the Pegylated Interferon and Ribavirin Treatment Predicts Sustained Virological Response. American Journal of Therapeutics 2016; 23(6): e1612 doi: 10.1097/MJT.0000000000000279
|
| 27 |
Claudia Della Corte, Antonella Mosca, Andrea Vania, Arianna Alterio, Anna Alisi, Valerio Nobili. Pediatric liver diseases: current challenges and future perspectives. Expert Review of Gastroenterology & Hepatology 2016; 10(2): 255 doi: 10.1586/17474124.2016.1129274
|
| 28 |
Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar. Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-αBased Therapy. Mediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/287640
|
| 29 |
V. Stalin Raj, Gadissa Bedada Hundie, Anita C. Schürch, Saskia L. Smits, Suzan D. Pas, Sophie Le Pogam, Harry L. A. Janssen, Rob J. de Knegt, Albert D. M. E. Osterhaus, Isabel Najera, Charles A. Boucher, Bart L. Haagmans. Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04931-y
|
| 30 |
Ben X. Wang, Eleanor N. Fish. The yin and yang of viruses and interferons. Trends in Immunology 2012; 33(4): 190 doi: 10.1016/j.it.2012.01.004
|
| 31 |
Samar E. Ghanem, Maha Elsabaawy, Nashwa shebl, Eman Abdelsameea, Warda Othman, Fathia I. EL‑Bassal, Gamalat A. Elgedawy, Dalia M. Elsabaawy, Marwa L. Helal. Value of IFNL3 genetic polymorphism in the prediction of HCV treatment response to direct-acting antiviral drugs versus interferon therapy. Expert Review of Anti-infective Therapy 2020; 18(9): 947 doi: 10.1080/14787210.2020.1771180
|
| 32 |
Yin Mi, Ying Tang Gao, Xiao Lei Jiao, Hua Guo, Tong Liu, Li Jing, Wen Xia Shi, Zhi Du. The Role of Interleukin-28b Gene Polymorphisms in Chinese Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin. Hepatitis Monthly 2014; 14(8) doi: 10.5812/hepatmon.18793
|
| 33 |
Hannah Perkins, Tansi Khodai, Houria Mechiche, Peter Colman, Frances Burden, Carl Laxton, Nigel Horscroft, Tom Corey, Deborah Rodrigues, Jaiessh Rawal, Jonathan Heyen, Mark Fidock, Mike Westby, Helen Bright. Therapy with TLR7 Agonists Induces Lymphopenia: Correlating Pharmacology to Mechanism in a Mouse Model. Journal of Clinical Immunology 2012; 32(5): 1082 doi: 10.1007/s10875-012-9687-y
|
| 34 |
Naveen Kumar, Shalini Sharma, Ram Kumar, Bhupendra N. Tripathi, Sanjay Barua, Hinh Ly, Barry T. Rouse. Host-Directed Antiviral Therapy. Clinical Microbiology Reviews 2020; 33(3) doi: 10.1128/CMR.00168-19
|
| 35 |
Abolfazl Fateh, Mohammad Reza Aghasadeghi, Hossein Keyvani, Hamid Reza Mollaie, Shamsi Yari, Ali Reza Hadizade Tasbiti, Morteza Ghazanfari, Seyed Hamid Reza Monavari. High Resolution Melting Curve Assay for Detecting rs12979860 IL28B Polymorphisms Involved in Response of Iranian Patients to Chronic Hepatitis C Treatment. Asian Pacific Journal of Cancer Prevention 2015; 16(5): 1873 doi: 10.7314/APJCP.2015.16.5.1873
|
| 36 |
Nadia Kandoussi, Hicham Elannaz, Marouan Melloul, Reda Tagajdid Mohamed, Rachid Abi, Abdelaziz Elalaoui My, Sanaa Alaoui Amine, Nadia Touil, Elmostafa Elfahime, Saâd Elkabbaj, Mimoun Zouhdi, Saâd Mrani. Genetic variation in interleukin 28B rs8099917 and response to antiviral therapy in Moroccan patients with chronic hepatitis C. Gene Reports 2017; 8: 84 doi: 10.1016/j.genrep.2017.06.003
|
| 37 |
Simone Moreira, Raquel Francine Liermann Garcia, Andréia Gutberlet, Bruna Cristina Bertol, Leslie Ecker Ferreira, Mauro de Souza Leite Pinho, Paulo Henrique Condeixa de França. A straightforward genotyping of the relevant IL28B SNPs for the prediction of hepatitis C treatment outcome. Journal of Virological Methods 2012; 184(1-2): 93 doi: 10.1016/j.jviromet.2012.05.024
|
| 38 |
Mona Halawani. Hepatitis C virus genotypes among patients with lichen planus in the Kingdom of Saudi Arabia. International Journal of Dermatology 2014; 53(2): 171 doi: 10.1111/j.1365-4632.2012.05685.x
|